Learning Objectives:
1. Evaluate evolving strategies for prostate cancer risk stratification, personalized treatment, and multidisciplinary care across all disease stages.
2. Assess the roles of genetic testing, genomic profiling, biomarkers, and artificial intelligence in prostate cancer diagnosis and treatment selection.
3. Compare advances in localized prostate cancer management, including active surveillance, surgery, radiation therapy, focal therapy, and multimodal approaches.
4. Analyze emerging diagnostic technologies, including PSMA PET, advanced MRI, image-guided biopsies, and molecular biomarkers.
5. Evaluate current approaches to androgen deprivation therapy (ADT), treatment-related side effects, and comprehensive survivorship care.
6. Examine advances in systemic therapies for advanced prostate cancer, including androgen receptor pathway inhibitors, PARP inhibitors, immunotherapies, and radioligand therapies.
7. Interpret emerging clinical trial findings and their potential impact on prostate cancer diagnosis, treatment sequencing, and patient outcomes.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Carden Jennings Publishing. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Amedco Joint Accreditation Provider Number: 4008163
Professions in scope for this activity are listed below:
Physicians
Amedco LLC designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Up to 13.5 hours.
Physician Assistants
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification for PAs.
Amedco LLC designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. PAs should claim only the credit commensurate with the extent of their participation in the activity.